Potential Roles of FGF5 as a Candidate Therapeutic Target in Prostate Cancer

    January 2023 in “ PubMed
    Mary M. Stangis, Avan N Colah, Dalton McLean, Richard B. Halberg, Lara S. Collier, William A. Ricke
    Studysummary This review discusses the potential role of FGF5 as a therapeutic target in prostate cancer and other conditions but reports no new results, highlighting a need for further research on FGF5 inhibitors.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results